Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.06 trillion and total revenue of $110.2 billion.
Market Cap
1.06T
Revenue
110.2B
Profits
-41.75B
PE Ratio
n/a
Profit Margin
-37.89%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.36B | 1.43% | 1,300,075 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.96B | -0.90% | 628,268 | 14.34B |
| 3 | ARGX | argenx SE | 42.36B | -0.04% | 340,554 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.26B | -1.18% | 663,588 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 31.34B | 0.15% | 103,120 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.04B | 0.91% | 1,952,611 | 606.42M |
| 7 | BNTX | BioNTech SE | 22.45B | -0.77% | 1,698,818 | 3.37B |
| 8 | MRNA | Moderna, Inc. | 20.68B | -0.06% | 4,880,960 | 1.94B |
| 9 | ROIV | Roivant Sciences Ltd. | 19.90B | - | 4,023,699 | 13.31M |
| 10 | RVMD | Revolution Medicines, Inc. | 19.68B | 1.20% | 1,488,999 | - |
| 11 | RPRX | Royalty Pharma plc | 19.51B | -0.57% | 2,763,989 | 2.38B |
| 12 | INCY | Incyte Corporation | 18.50B | 0.77% | 1,331,572 | 5.14B |
| 13 | GMAB | Genmab A/S | 15.59B | -0.46% | 1,320,346 | 3.72B |
| 14 | ASND | Ascendis Pharma A/S | 13.74B | -1.58% | 556,690 | 845.52M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 13.58B | -0.07% | 1,167,282 | 502.08M |
| 16 | SMMT | Summit Therapeutics Inc. | 12.19B | 0.77% | 1,610,305 | - |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 11.78B | -0.49% | 2,247,918 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 11.19B | 0.75% | 603,242 | 4.27B |
| 19 | EXEL | Exelixis, Inc. | 10.72B | - | 2,095,346 | 2.32B |
| 20 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | -0.72% | 1,890,255 | 3.22B |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.42B | 2.76% | 281,945 | 958.40M |
| 22 | ABVX | ABIVAX Société Anonyme | 9.58B | -0.78% | 735,200 | 6.23M |
| 23 | IBRX | ImmunityBio, Inc. | 9.07B | 3.04% | 17,916,537 | 113.29M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.29B | 3.02% | 430,505 | 7.46M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.13B | 0.64% | 454,762 | 638.50M |
| 26 | TECH | Bio-Techne Corporation | 8.07B | 1.54% | 2,381,908 | 1.22B |
| 27 | ARWR | Arrowhead Pharmaceuticals, Inc. | 7.98B | 0.44% | 1,910,288 | 1.09B |
| 28 | PCVX | Vaxcyte, Inc. | 7.77B | -0.55% | 1,282,432 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 7.75B | 1.22% | 1,849,421 | 88.04M |
| 30 | NUVL | Nuvalent, Inc. | 7.63B | -0.38% | 447,751 | - |
| 31 | KRYS | Krystal Biotech, Inc. | 7.54B | 2.86% | 233,120 | 389.13M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 7.47B | -0.60% | 1,423,003 | 1.40B |
| 33 | ACLX | Arcellx, Inc. | 6.69B | -0.16% | 1,436,214 | 22.29M |
| 34 | KYMR | Kymera Therapeutics, Inc. | 6.50B | 0.54% | 460,440 | 39.21M |
| 35 | PTGX | Protagonist Therapeutics, Inc. | 6.49B | 4.73% | 1,919,750 | 46.02M |
| 36 | BLTE | Belite Bio, Inc | 6.26B | -1.30% | 140,318 | - |
| 37 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.17B | 5.18% | 1,002,579 | 189.76M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.62B | 0.70% | 2,120,405 | - |
| 39 | CGON | CG Oncology, Inc. | 5.56B | 2.19% | 1,955,593 | 4.04M |
| 40 | PTCT | PTC Therapeutics, Inc. | 5.55B | 0.11% | 895,564 | 1.73B |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.47B | -1.03% | 962,222 | 521.31M |
| 42 | CAI | Caris Life Sciences, Inc. | 5.31B | 1.84% | 3,268,694 | 812.03M |
| 43 | XENE | Xenon Pharmaceuticals Inc. | 5.26B | 0.18% | 1,489,350 | 7.50M |
| 44 | CELC | Celcuity Inc. | 5.23B | 0.43% | 576,923 | - |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.23B | 14.35% | 3,748,500 | - |
| 46 | TGTX | TG Therapeutics, Inc. | 4.85B | 1.07% | 3,320,416 | 616.29M |
| 47 | IMVT | Immunovant, Inc. | 4.81B | 0.21% | 1,002,594 | - |
| 48 | APGE | Apogee Therapeutics, Inc. | 4.76B | 2.59% | 647,348 | - |
| 49 | ERAS | Erasca, Inc. | 4.74B | 13.04% | 6,593,117 | - |
| 50 | FOLD | Amicus Therapeutics, Inc. | 4.52B | 0.07% | 3,491,230 | 634.21M |
| 51 | CRSP | CRISPR Therapeutics AG | 4.51B | -1.55% | 2,235,905 | 3.51M |
| 52 | TERN | Terns Pharmaceuticals, Inc. | 4.42B | 2.68% | 3,617,371 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 4.20B | 0.46% | 149,567 | 268.09M |
| 54 | VKTX | Viking Therapeutics, Inc. | 3.92B | 1.10% | 1,938,008 | - |
| 55 | CNTA | Centessa Pharmaceuticals plc | 3.81B | -1.29% | 1,244,272 | 15.00M |
| 56 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.75B | -0.64% | 928,294 | 7.70M |
| 57 | CORT | Corcept Therapeutics Incorporated | 3.63B | 2.34% | 1,266,431 | 761.41M |
| 58 | ADMA | ADMA Biologics, Inc. | 3.58B | 1.01% | 5,615,903 | 510.17M |
| 59 | GPCR | Structure Therapeutics Inc. | 3.57B | -2.76% | 901,401 | - |
| 60 | DNTH | Dianthus Therapeutics, Inc. | 3.56B | 1.45% | 733,850 | 2.04M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 3.53B | 1.97% | 2,419,864 | 1.07B |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.50B | 3.46% | 1,211,049 | 22.50M |
| 63 | SYRE | Spyre Therapeutics, Inc. | 3.32B | -1.74% | 628,435 | - |
| 64 | LEGN | Legend Biotech Corporation | 3.30B | -1.87% | 1,446,538 | 1.03B |
| 65 | ALMS | Alumis Inc. | 3.23B | -0.16% | 719,747 | 24.05M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.22B | 1.21% | 659,433 | - |
| 67 | DNLI | Denali Therapeutics Inc. | 3.13B | -1.55% | 1,381,526 | - |
| 68 | VERA | Vera Therapeutics, Inc. | 2.95B | 7.96% | 1,574,952 | - |
| 69 | DYN | Dyne Therapeutics, Inc. | 2.94B | -2.68% | 2,052,215 | - |
| 70 | TLX | Telix Pharmaceuticals Limited | 2.90B | 1.90% | 332,988 | 803.79M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 2.86B | -2.13% | 671,018 | 218.71M |
| 72 | VRDN | Viridian Therapeutics, Inc. | 2.85B | 0.40% | 947,860 | 70.85M |
| 73 | ARQT | Arcutis Biotherapeutics, Inc. | 2.84B | 3.01% | 1,283,076 | 376.07M |
| 74 | TARS | Tarsus Pharmaceuticals, Inc. | 2.84B | -2.18% | 463,722 | 451.36M |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.81B | 0.99% | 826,466 | 247.00M |
| 76 | TNGX | Tango Therapeutics, Inc. | 2.76B | 3.43% | 3,173,819 | 62.38M |
| 77 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.73B | -2.10% | 1,040,603 | 588.99M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.56B | -0.59% | 1,406,820 | 139.74M |
| 79 | TVTX | Travere Therapeutics, Inc. | 2.56B | 2.82% | 1,208,537 | 490.73M |
| 80 | MAZE | Maze Therapeutics, Inc. | 2.38B | 1.98% | 649,054 | 2.50M |
| 81 | IMNM | Immunome, Inc. | 2.36B | 1.02% | 1,150,561 | 6.94M |
| 82 | APLS | Apellis Pharmaceuticals, Inc. | 2.30B | 0.45% | 2,347,902 | 1.00B |
| 83 | WVE | Wave Life Sciences Ltd. | 2.28B | 1.85% | 2,295,822 | 42.73M |
| 84 | IRON | Disc Medicine, Inc. | 2.26B | 0.05% | 452,880 | - |
| 85 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.38% | 6,729,235 | 158.18M |
| 86 | NKTR | Nektar Therapeutics | 2.15B | 2.27% | 572,513 | 55.23M |
| 87 | GLPG | Galapagos NV | 2.14B | 1.12% | 96,080 | 1.31B |
| 88 | MANE | Veradermics, Incorporated | 2.12B | -3.56% | 620,474 | - |
| 89 | SNDX | Syndax Pharmaceuticals, Inc. | 2.12B | 1.48% | 1,305,213 | 172.35M |
| 90 | ADPT | Adaptive Biotechnologies Corporation | 2.08B | 1.66% | 1,336,947 | 276.98M |
| 91 | ZLAB | Zai Lab Limited | 2.06B | -1.17% | 813,938 | 460.16M |
| 92 | TYRA | Tyra Biosciences, Inc. | 2.06B | 0.34% | 934,808 | - |
| 93 | AAPG | Ascentage Pharma Group International | 2.05B | -8.36% | 2,773 | 54.52M |
| 94 | CLDX | Celldex Therapeutics, Inc. | 2.00B | 5.22% | 1,043,838 | 1.55M |
| 95 | RARE | Ultragenyx Pharmaceutical Inc. | 1.97B | -0.20% | 1,654,061 | 673.00M |
| 96 | STOK | Stoke Therapeutics, Inc. | 1.96B | 7.00% | 858,572 | 184.42M |
| 97 | ORKA | Oruka Therapeutics, Inc. | 1.92B | -4.85% | 649,967 | - |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 1.92B | -2.59% | 1,423,187 | - |
| 99 | MESO | Mesoblast Limited | 1.90B | 1.03% | 145,365 | 65.38M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 1.87B | -0.07% | 783,131 | 283.06M |
| 101 | ANAB | AnaptysBio, Inc. | 1.86B | - | 759,747 | 234.60M |
| 102 | DFTX | Definium Therapeutics, Inc. | 1.86B | 5.78% | 1,444,917 | - |
| 103 | OCUL | Ocular Therapeutix, Inc. | 1.80B | -2.59% | 3,029,572 | 51.95M |
| 104 | ELVN | Enliven Therapeutics, Inc. | 1.80B | 10.28% | 4,934,979 | - |
| 105 | CAPR | Capricor Therapeutics, Inc. | 1.79B | 0.87% | 1,256,148 | 11.13M |
| 106 | RLAY | Relay Therapeutics, Inc. | 1.79B | 0.70% | 1,264,675 | 15.36M |
| 107 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | 1.51% | 11,311,255 | 74.68M |
| 108 | ZYME | Zymeworks Inc. | 1.76B | 1.90% | 577,249 | 105.97M |
| 109 | SRPT | Sarepta Therapeutics, Inc. | 1.75B | -2.97% | 2,812,513 | 2.20B |
| 110 | SLNO | Soleno Therapeutics, Inc. | 1.74B | 2.47% | 1,180,747 | 190.41M |
| 111 | VCEL | Vericel Corporation | 1.66B | 1.36% | 865,096 | 276.26M |
| 112 | INVA | Innoviva, Inc. | 1.64B | 0.91% | 698,399 | 411.33M |
| 113 | AGIO | Agios Pharmaceuticals, Inc. | 1.64B | -0.75% | 605,936 | 54.03M |
| 114 | HRMY | Harmony Biosciences Holdings, Inc. | 1.61B | -0.14% | 791,925 | 868.45M |
| 115 | SION | Sionna Therapeutics, Inc. | 1.60B | 3.17% | 218,953 | - |
| 116 | IOVA | Iovance Biotherapeutics, Inc. | 1.59B | 2.65% | 10,477,127 | 263.50M |
| 117 | NVAX | Novavax, Inc. | 1.59B | -2.70% | 3,876,731 | 1.12B |
| 118 | GENB | Generate Biomedicines, Inc. | 1.57B | 4.06% | 459,072 | 31.89M |
| 119 | NTLA | Intellia Therapeutics, Inc. | 1.55B | -0.45% | 2,742,697 | 67.67M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.53B | -0.86% | 1,199,849 | 83.98M |
| 121 | NBTX | Nanobiotix S.A. | 1.53B | -3.20% | 65,700 | 11.93M |
| 122 | IMCR | Immunocore Holdings plc | 1.52B | - | 261,362 | 400.02M |
| 123 | OCS | Oculis Holding AG | 1.50B | -3.54% | 473,514 | 1.51M |
| 124 | NUVB | Nuvation Bio Inc. | 1.48B | -0.47% | 3,564,339 | 62.90M |
| 125 | PHVS | Pharvaris N.V. | 1.43B | -0.15% | 123,171 | - |
| 126 | TRVI | Trevi Therapeutics, Inc. | 1.37B | 0.09% | 1,243,292 | - |
| 127 | MBX | MBX Biosciences, Inc. | 1.35B | -0.94% | 434,375 | - |
| 128 | ARDX | Ardelyx, Inc. | 1.35B | -0.90% | 3,407,874 | 407.32M |
| 129 | PVLA | Palvella Therapeutics, Inc. | 1.35B | -0.28% | 212,581 | - |
| 130 | BHVN | Biohaven Ltd. | 1.35B | -1.43% | 1,541,656 | - |
| 131 | ZBIO | Zenas BioPharma, Inc. | 1.34B | 1.48% | 376,538 | 10.00M |
| 132 | RAPP | Rapport Therapeutics, Inc. | 1.31B | 3.70% | 328,048 | - |
| 133 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | 2.47% | 5,664,049 | 9.77M |
| 134 | VIR | Vir Biotechnology, Inc. | 1.31B | 0.64% | 1,969,324 | 68.56M |
| 135 | OLMA | Olema Pharmaceuticals, Inc. | 1.30B | 2.68% | 1,503,102 | - |
| 136 | IMTX | Immatics N.V. | 1.30B | 0.31% | 584,209 | 56.67M |
| 137 | ATAI | AtaiBeckley Inc. | 1.30B | 0.28% | 4,967,851 | 4.09M |
| 138 | GLUE | Monte Rosa Therapeutics, Inc. | 1.29B | 1.90% | 1,105,263 | 123.67M |
| 139 | KOD | Kodiak Sciences Inc. | 1.20B | 2.65% | 708,150 | - |
| 140 | MLTX | MoonLake Immunotherapeutics | 1.20B | 2.77% | 905,385 | - |
| 141 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | 0.07% | 1,233,164 | - |
| 142 | PGEN | Precigen, Inc. | 1.17B | 1.53% | 4,021,629 | 6.31M |
| 143 | DMRA | Damora Therapeutics, Inc. | 1.16B | -9.22% | 422,578 | - |
| 144 | EYPT | EyePoint, Inc. | 1.15B | 1.10% | 886,564 | 31.37M |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.11B | 2.21% | 1,273,232 | - |
| 146 | SEPN | Septerna, Inc. | 1.09B | 0.71% | 283,195 | 45.95M |
| 147 | TVGN | Tevogen Bio Holdings Inc. | 1.07B | -0.38% | 23,116 | - |
| 148 | ABCL | AbCellera Biologics Inc. | 1.07B | 0.28% | 2,407,727 | 75.13M |
| 149 | PHAR | Pharming Group N.V. | 1.06B | 1.38% | 6,566 | 376.13M |
| 150 | SVRA | Savara Inc. | 1.06B | 2.38% | 2,284,905 | - |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.03B | 2.06% | 477,680 | - |
| 152 | AVBP | ArriVent BioPharma, Inc. | 1.01B | 0.22% | 339,607 | - |
| 153 | GERN | Geron Corporation | 992.84M | - | 22,187,158 | 183.88M |
| 154 | CMPX | Compass Therapeutics, Inc. | 970.67M | 1.32% | 1,992,941 | 850.00K |
| 155 | XERS | Xeris Biopharma Holdings, Inc. | 962.17M | 2.76% | 1,273,798 | 291.85M |
| 156 | QURE | uniQure N.V. | 954.20M | 3.60% | 1,780,197 | 16.10M |
| 157 | INBX | Inhibrx Biosciences, Inc. | 947.56M | -5.56% | 184,152 | 1.30M |
| 158 | AKTS | Aktis Oncology, Inc. | 944.35M | -1.64% | 469,728 | 5.56M |
| 159 | SLS | SELLAS Life Sciences Group, Inc. | 933.83M | 5.05% | 5,853,986 | - |
| 160 | GHRS | GH Research PLC | 918.66M | -1.40% | 105,239 | - |
| 161 | FTRE | Fortrea Holdings Inc. | 915.37M | -1.51% | 1,152,468 | 2.72B |
| 162 | VALN | Valneva SE | 910.00M | -6.21% | 10,310 | 205.07M |
| 163 | URGN | UroGen Pharma Ltd. | 905.00M | 0.60% | 350,846 | 109.79M |
| 164 | XNCR | Xencor, Inc. | 888.86M | 4.57% | 852,418 | 125.58M |
| 165 | PHAT | Phathom Pharmaceuticals, Inc. | 878.61M | 1.73% | 816,666 | 175.11M |
| 166 | JANX | Janux Therapeutics, Inc. | 861.38M | 2.16% | 1,034,059 | 10.00M |
| 167 | SGP | SpyGlass Pharma, Inc. | 856.59M | -4.07% | 198,317 | - |
| 168 | EVMN | Evommune, Inc. | 848.59M | -2.20% | 158,937 | 13.00M |
| 169 | SANA | Sana Biotechnology, Inc. | 845.97M | 1.28% | 2,646,828 | - |
| 170 | IVA | Inventiva S.A. | 840.47M | 1.34% | 191,308 | 19.93M |
| 171 | ABUS | Arbutus Biopharma Corporation | 840.46M | 2.82% | 1,769,324 | 14.61M |
| 172 | KALV | KalVista Pharmaceuticals, Inc. | 830.48M | 6.07% | 1,067,199 | 1.43M |
| 173 | SPRY | ARS Pharmaceuticals, Inc. | 819.20M | -0.60% | 885,625 | 84.28M |
| 174 | ANL | Adlai Nortye Ltd. | 814.76M | -0.67% | 146,755 | -1.35M |
| 175 | CTMX | CytomX Therapeutics, Inc. | 813.49M | 8.64% | 13,433,505 | 76.20M |
| 176 | CGEM | Cullinan Therapeutics, Inc. | 791.68M | -0.38% | 584,262 | - |
| 177 | OMER | Omeros Corporation | 788.41M | 1.55% | 650,431 | - |
| 178 | MNKD | MannKind Corporation | 776.41M | -3.45% | 4,640,832 | 348.97M |
| 179 | MPLT | MapLight Therapeutics, Inc. | 763.29M | 2.76% | 286,781 | - |
| 180 | KURA | Kura Oncology, Inc. | 744.62M | 0.48% | 800,117 | 67.48M |
| 181 | OCGN | Ocugen, Inc. | 734.49M | -2.18% | 8,845,311 | 4.41M |
| 182 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 724.30M | 1.91% | 78,899 | - |
| 183 | DRUG | Bright Minds Biosciences Inc. | 714.81M | 3.48% | 224,018 | - |
| 184 | ARVN | Arvinas, Inc. | 714.44M | 2.57% | 1,235,748 | 262.60M |
| 185 | TBPH | Theravance Biopharma, Inc. | 709.92M | 1.30% | 788,907 | 107.46M |
| 186 | ANRO | Alto Neuroscience, Inc. | 704.08M | -2.13% | 347,469 | - |
| 187 | SLDB | Solid Biosciences Inc. | 700.55M | - | 1,007,088 | - |
| 188 | JBIO | Jade Biosciences, Inc. | 694.37M | 2.18% | 318,161 | - |
| 189 | LXRX | Lexicon Pharmaceuticals, Inc. | 686.36M | 3.85% | 1,456,881 | 49.80M |
| 190 | PRME | Prime Medicine, Inc. | 664.43M | 4.25% | 2,253,299 | 4.63M |
| 191 | GYRE | Gyre Therapeutics, Inc. | 659.35M | -3.00% | 201,676 | 116.59M |
| 192 | ANNX | Annexon, Inc. | 656.78M | 1.29% | 2,741,087 | - |
| 193 | RLMD | Relmada Therapeutics, Inc. | 655.56M | 0.64% | 1,191,065 | - |
| 194 | DRTS | Alpha Tau Medical Ltd. | 644.23M | 0.14% | 291,471 | - |
| 195 | DSGN | Design Therapeutics, Inc. | 632.76M | -0.39% | 175,114 | - |
| 196 | MDXG | MiMedx Group, Inc. | 619.52M | -1.65% | 804,976 | 418.63M |
| 197 | AGMB | AgomAb Therapeutics NV | 618.96M | -8.30% | 445,557 | - |
| 198 | LBRX | LB Pharmaceuticals Inc | 606.93M | 0.97% | 225,258 | - |
| 199 | EIKN | Eikon Therapeutics, Inc. | 592.75M | -6.47% | 483,188 | - |
| 200 | MGTX | MeiraGTx Holdings plc | 591.61M | -1.08% | 255,538 | 27.42M |
| 201 | ZURA | Zura Bio Limited | 580.67M | 2.17% | 771,242 | - |
| 202 | TECX | Tectonic Therapeutic, Inc. | 578.88M | -4.11% | 291,116 | - |
| 203 | REPL | Replimune Group, Inc. | 568.93M | 1.92% | 1,223,110 | - |
| 204 | ZVRA | Zevra Therapeutics, Inc. | 551.89M | -1.57% | 648,600 | 106.47M |
| 205 | ALLO | Allogene Therapeutics, Inc. | 541.19M | 3.26% | 3,367,934 | 22.00K |
| 206 | DBVT | DBV Technologies S.A. | 532.40M | - | 129,209 | 5.50M |
| 207 | ADCT | ADC Therapeutics SA | 513.26M | 0.75% | 429,805 | 81.36M |
| 208 | VSTM | Verastem, Inc. | 511.20M | 4.68% | 2,186,118 | 30.91M |
| 209 | VNDA | Vanda Pharmaceuticals Inc. | 506.56M | 0.12% | 1,069,104 | 216.11M |
| 210 | CRMD | CorMedix Inc. | 498.02M | -1.10% | 1,257,258 | 311.71M |
| 211 | LYEL | Lyell Immunopharma, Inc. | 484.09M | 3.54% | 69,455 | 36.00K |
| 212 | ENGN | enGene Holdings Inc. | 483.33M | 0.49% | 149,494 | - |
| 213 | RIGL | Rigel Pharmaceuticals, Inc. | 482.15M | 2.59% | 402,415 | 294.28M |
| 214 | AVIR | Atea Pharmaceuticals, Inc. | 478.03M | 1.52% | 519,222 | - |
| 215 | RCKT | Rocket Pharmaceuticals, Inc. | 476.62M | -1.79% | 3,078,430 | - |
| 216 | EPRX | Eupraxia Pharmaceuticals Inc. | 470.90M | 1.20% | 354,969 | - |
| 217 | FULC | Fulcrum Therapeutics, Inc. | 468.87M | 1.73% | 1,445,096 | 80.00M |
| 218 | LRMR | Larimar Therapeutics, Inc. | 464.36M | 3.95% | 2,445,298 | - |
| 219 | ABSI | Absci Corporation | 463.14M | 7.69% | 3,810,668 | 2.82M |
| 220 | PRTA | Prothena Corporation plc | 459.73M | -0.58% | 467,774 | 9.68M |
| 221 | TRDA | Entrada Therapeutics, Inc. | 458.65M | 0.84% | 207,935 | 25.42M |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 458.44M | 4.91% | 731,910 | 85.21M |
| 223 | UPB | Upstream Bio, Inc. | 452.84M | -3.34% | 734,938 | 2.80M |
| 224 | CTNM | Contineum Therapeutics, Inc. | 452.14M | -0.90% | 130,064 | - |
| 225 | ACRS | Aclaris Therapeutics, Inc. | 451.03M | 2.19% | 1,376,435 | 7.83M |
| 226 | IPSC | Century Therapeutics, Inc. | 447.51M | 8.26% | 1,629,626 | 109.16M |
| 227 | ALT | Altimmune, Inc. | 444.84M | - | 2,686,763 | 41.00K |
| 228 | MRVI | Maravai LifeSciences Holdings, Inc. | 443.54M | -0.66% | 1,571,834 | 185.74M |
| 229 | STTK | Shattuck Labs, Inc. | 436.54M | 0.99% | 709,715 | 1.00M |
| 230 | ASMB | Assembly Biosciences, Inc. | 436.38M | -0.04% | 57,014 | 72.30M |
| 231 | RGNX | REGENXBIO Inc. | 431.48M | 0.97% | 739,531 | 170.44M |
| 232 | NMRA | Neumora Therapeutics, Inc. | 429.42M | -2.65% | 956,406 | - |
| 233 | LXEO | Lexeo Therapeutics, Inc. | 422.60M | 0.52% | 636,339 | - |
| 234 | AURA | Aura Biosciences, Inc. | 417.85M | - | 314,955 | - |
| 235 | IVVD | Invivyd, Inc. | 409.76M | -3.97% | 1,506,374 | 53.43M |
| 236 | DNA | Ginkgo Bioworks Holdings, Inc. | 407.17M | 6.47% | 849,504 | 170.16M |
| 237 | BNTC | Benitec Biopharma Inc. | 395.07M | -1.54% | 119,943 | - |
| 238 | MNPR | Monopar Therapeutics Inc. | 392.07M | 0.63% | 194,523 | - |
| 239 | PRTC | PureTech Health plc | 390.41M | -0.06% | 881 | 6.39M |
| 240 | AVXL | Anavex Life Sciences Corp. | 389.22M | -1.41% | 1,576,963 | - |
| 241 | LCTX | Lineage Cell Therapeutics, Inc. | 386.09M | 3.33% | 1,160,442 | 14.56M |
| 242 | YDES | YD Bio Limited | 381.13M | -14.51% | 32,232 | 510.36K |
| 243 | AUTL | Autolus Therapeutics plc | 380.58M | -1.38% | 1,243,715 | 51.13M |
| 244 | NAGE | Niagen Bioscience, Inc. | 379.58M | 4.18% | 1,314,714 | 129.42M |
| 245 | XFOR | X4 Pharmaceuticals, Inc. | 379.14M | 2.96% | 260,409 | 35.11M |
| 246 | ENTA | Enanta Pharmaceuticals, Inc. | 377.25M | 2.36% | 134,040 | 66.98M |
| 247 | KYTX | Kyverna Therapeutics, Inc. | 374.02M | - | 465,349 | - |
| 248 | DMAC | DiaMedica Therapeutics Inc. | 365.58M | -1.40% | 254,402 | - |
| 249 | CADL | Candel Therapeutics, Inc. | 359.64M | -2.58% | 1,196,144 | - |
| 250 | LENZ | LENZ Therapeutics, Inc. | 359.52M | -1.96% | 685,156 | 17.50M |
| 251 | GLSI | Greenwich LifeSciences, Inc. | 358.56M | -3.11% | 190,728 | - |
| 252 | NERV | Minerva Neurosciences, Inc. | 349.22M | 3.73% | 638,356 | - |
| 253 | NAUT | Nautilus Biotechnology, Inc. | 347.34M | 0.36% | 218,117 | - |
| 254 | XOMA | XOMA Royalty Corporation | 342.41M | 5.16% | 105,510 | 52.15M |
| 255 | CLYM | Climb Bio, Inc. | 333.42M | -1.97% | 668,887 | - |
| 256 | PEPG | PepGen Inc. | 329.68M | -6.84% | 464,016 | - |
| 257 | IRD | Opus Genetics, Inc. | 325.86M | -1.72% | 987,688 | 14.20M |
| 258 | IMMX | Immix Biopharma, Inc. | 325.03M | 2.33% | 994,503 | - |
| 259 | BCYC | Bicycle Therapeutics plc | 317.17M | -3.19% | 567,075 | 72.59M |
| 260 | IMRX | Immuneering Corporation | 314.21M | 1.67% | 1,108,682 | - |
| 261 | PBYI | Puma Biotechnology, Inc. | 312.89M | 2.50% | 270,583 | 228.37M |
| 262 | NBP | NovaBridge Biosciences | 310.13M | -4.61% | 516,517 | - |
| 263 | FBRX | Forte Biosciences, Inc. | 308.29M | -0.97% | 199,566 | - |
| 264 | OVID | Ovid Therapeutics Inc. | 303.31M | - | 5,457,476 | 7.25M |
| 265 | SLN | Silence Therapeutics plc | 301.35M | -3.77% | 273,627 | 559.00K |
| 266 | ARMP | Armata Pharmaceuticals, Inc. | 301.17M | -2.93% | 28,444 | 5.05M |
| 267 | ACIU | AC Immune SA | 300.23M | -4.53% | 141,823 | 4.51M |
| 268 | NGNE | Neurogene Inc. | 297.25M | -1.59% | 192,991 | 925.00K |
| 269 | PALI | Palisade Bio, Inc. | 296.52M | 1.02% | 2,131,010 | - |
| 270 | CBIO | Crescent Biopharma, Inc. | 292.65M | 2.61% | 238,813 | 10.84M |
| 271 | CABA | Cabaletta Bio, Inc. | 292.65M | 2.36% | 1,526,206 | - |
| 272 | ALXO | ALX Oncology Holdings Inc. | 288.22M | 1.86% | 1,244,461 | - |
| 273 | FHTX | Foghorn Therapeutics Inc. | 287.04M | 0.20% | 192,685 | 30.91M |
| 274 | TARA | Protara Therapeutics, Inc. | 286.65M | 0.57% | 481,362 | - |
| 275 | PROK | ProKidney Corp. | 276.79M | -6.25% | 1,498,423 | 893.00K |
| 276 | CNTX | Context Therapeutics Inc. | 274.72M | 2.40% | 506,012 | - |
| 277 | OBIO | Orchestra BioMed Holdings, Inc. | 271.54M | 2.88% | 344,953 | 33.48M |
| 278 | CAMP | Camp4 Therapeutics Corporation | 267.90M | -3.19% | 95,982 | 3.50M |
| 279 | PLYX | Polaryx Therapeutics, Inc. | 267.49M | 2.17% | 662,203 | - |
| 280 | OABI | OmniAb, Inc. | 266.40M | 1.10% | 338,821 | 18.67M |
| 281 | ABEO | Abeona Therapeutics Inc. | 259.00M | -0.22% | 1,162,103 | 5.82M |
| 282 | AVTX | Avalo Therapeutics, Inc. | 257.87M | -3.13% | 868,445 | 192.00K |
| 283 | TENX | Tenax Therapeutics, Inc. | 256.42M | -4.24% | 289,187 | - |
| 284 | CCCC | C4 Therapeutics, Inc. | 254.68M | -2.97% | 2,023,767 | 35.95M |
| 285 | CLLS | Cellectis S.A. | 247.73M | 0.29% | 48,346 | 82.55M |
| 286 | CHRS | Coherus Oncology, Inc. | 241.32M | 1.90% | 900,427 | 42.17M |
| 287 | HELP | Cybin Inc. | 240.67M | 1.26% | 545,181 | - |
| 288 | RZLT | Rezolute, Inc. | 236.37M | 3.78% | 1,507,999 | - |
| 289 | EDIT | Editas Medicine, Inc. | 230.00M | - | 1,241,048 | 40.52M |
| 290 | SRZN | Surrozen, Inc. | 228.26M | 3.70% | 53,245 | 3.60M |
| 291 | SLGL | Sol-Gel Technologies Ltd. | 227.66M | 8.46% | 20,186 | 19.39M |
| 292 | ALEC | Alector, Inc. | 227.35M | 0.49% | 379,768 | 21.05M |
| 293 | VYGR | Voyager Therapeutics, Inc. | 222.90M | -0.53% | 504,095 | 40.37M |
| 294 | ELTX | Elicio Therapeutics, Inc. | 220.38M | 2.57% | 71,208 | - |
| 295 | KROS | Keros Therapeutics, Inc. | 219.26M | 1.55% | 458,706 | 244.06M |
| 296 | MDWD | MediWound Ltd. | 217.81M | -0.18% | 40,689 | 16.96M |
| 297 | ACHV | Achieve Life Sciences, Inc. | 217.73M | 1.24% | 313,218 | - |
| 298 | ELDN | Eledon Pharmaceuticals, Inc. | 216.18M | -5.00% | 1,537,430 | - |
| 299 | FENC | Fennec Pharmaceuticals Inc. | 215.09M | 2.41% | 141,756 | 38.79M |
| 300 | NVCT | Nuvectis Pharma, Inc. | 214.05M | -1.70% | 48,114 | - |
| 301 | TNXP | Tonix Pharmaceuticals Holding Corp. | 211.40M | 11.13% | 929,699 | 13.11M |
| 302 | PRLD | Prelude Therapeutics Incorporated | 200.98M | 2.24% | 191,059 | 12.14M |
| 303 | CGEN | Compugen Ltd. | 199.51M | -2.76% | 184,627 | 72.76M |
| 304 | SABS | SAB Biotherapeutics, Inc. | 192.59M | 2.16% | 552,564 | 114.70K |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 191.00M | 2.60% | 394,959 | 82.03M |
| 306 | CRBU | Caribou Biosciences, Inc. | 190.38M | 3.14% | 1,554,225 | 11.16M |
| 307 | ZNTL | Zentalis Pharmaceuticals, Inc. | 184.96M | 1.79% | 319,067 | 26.87M |
| 308 | MGNX | MacroGenics, Inc. | 184.31M | -2.68% | 781,529 | 149.50M |
| 309 | CBUS | Cibus, Inc. | 184.06M | -3.97% | 448,628 | 3.79M |
| 310 | NTHI | NeOnc Technologies Holdings, Inc. | 181.54M | -1.36% | 35,086 | 59.99K |
| 311 | GALT | Galectin Therapeutics Inc. | 180.52M | -0.53% | 354,485 | - |
| 312 | STRO | Sutro Biopharma, Inc. | 179.81M | -3.07% | 170,884 | 105.65M |
| 313 | PLX | Protalix BioTherapeutics, Inc. | 179.34M | 0.90% | 1,329,772 | 52.74M |
| 314 | ABOS | Acumen Pharmaceuticals, Inc. | 176.87M | - | 577,576 | - |
| 315 | MOLN | Molecular Partners AG | 175.46M | 3.19% | 1,866 | 856.30K |
| 316 | TNYA | Tenaya Therapeutics, Inc. | 174.40M | -2.29% | 4,427,047 | - |
| 317 | RNAC | Cartesian Therapeutics, Inc. | 174.16M | -1.20% | 111,436 | 2.80M |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 174.13M | -3.57% | 632,463 | - |
| 319 | ADAG | Adagene Inc. | 173.91M | -6.35% | 66,106 | 103.20K |
| 320 | MIST | Milestone Pharmaceuticals Inc. | 172.69M | - | 1,293,471 | - |
| 321 | WHWK | Whitehawk Therapeutics, Inc. | 169.44M | -5.77% | 229,015 | 7.15M |
| 322 | PRQR | ProQR Therapeutics N.V. | 167.52M | -7.56% | 211,203 | 19.19M |
| 323 | EVAX | Evaxion A/S | 166.80M | 5.82% | 15,720 | 7.53M |
| 324 | DTIL | Precision BioSciences, Inc. | 166.16M | -4.41% | 507,880 | 34.26M |
| 325 | PMN | ProMIS Neurosciences, Inc. | 163.30M | 7.12% | 37,668 | - |
| 326 | CNTB | Connect Biopharma Holdings Limited | 160.44M | 5.51% | 171,657 | 762.00K |
| 327 | HUMA | Humacyte, Inc. | 159.95M | -19.42% | 52,324,316 | 1.57M |
| 328 | KRRO | Korro Bio, Inc. | 159.51M | -3.07% | 177,359 | 6.39M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 158.56M | -1.22% | 148,115 | - |
| 330 | SGMT | Sagimet Biosciences Inc. | 157.39M | -0.62% | 310,188 | - |
| 331 | KLRS | Kalaris Therapeutics, Inc. | 156.14M | -9.56% | 76,246 | - |
| 332 | VXRT | Vaxart, Inc. | 155.93M | 2.11% | 231,061 | 237.26M |
| 333 | NKTX | Nkarta, Inc. | 154.13M | -3.13% | 623,157 | - |
| 334 | HRTX | Heron Therapeutics, Inc. | 154.09M | -2.70% | 1,527,416 | 154.90M |
| 335 | CDXS | Codexis, Inc. | 151.75M | 13.61% | 1,995,431 | 70.39M |
| 336 | IMUX | Immunic, Inc. | 151.34M | 0.87% | 1,438,175 | - |
| 337 | UNCY | Unicycive Therapeutics, Inc. | 146.36M | 0.74% | 488,850 | - |
| 338 | AGEN | Agenus Inc. | 146.30M | 1.33% | 455,107 | 114.20M |
| 339 | ORMP | Oramed Pharmaceuticals Inc. | 143.69M | 1.12% | 90,817 | 2.00M |
| 340 | KPTI | Karyopharm Therapeutics Inc. | 141.80M | -7.98% | 759,748 | 146.07M |
| 341 | VTVT | vTv Therapeutics Inc. | 141.67M | -0.91% | 16,728 | 17.00K |
| 342 | ANTX | AN2 Therapeutics, Inc. | 140.53M | -15.37% | 690,678 | - |
| 343 | SPRO | Spero Therapeutics, Inc. | 139.16M | 0.41% | 201,826 | 40.55M |
| 344 | IKT | Inhibikase Therapeutics, Inc. | 137.57M | - | 1,058,947 | 1.00 |
| 345 | VOR | Vor Biopharma Inc. | 137.11M | 1.31% | 877,320 | - |
| 346 | ARTV | Artiva Biotherapeutics, Inc. | 136.44M | -4.83% | 137,198 | 251.00K |
| 347 | MENS | Jyong Biotech Ltd. | 132.88M | - | 107,647 | - |
| 348 | EQ | Equillium, Inc. | 130.31M | 0.47% | 251,129 | 4.39M |
| 349 | ACOG | Alpha Cognition Inc. | 126.97M | 1.57% | 23,330 | 7.43M |
| 350 | FATE | Fate Therapeutics, Inc. | 125.56M | 1.89% | 1,347,632 | 6.65M |
| 351 | CRDF | Cardiff Oncology, Inc. | 124.42M | 0.55% | 718,396 | 593.00K |
| 352 | BDTX | Black Diamond Therapeutics, Inc. | 123.17M | -0.92% | 343,098 | 70.00M |
| 353 | IPHA | Innate Pharma S.A. | 119.02M | -3.05% | 8,383 | 14.84M |
| 354 | SGMO | Sangamo Therapeutics, Inc. | 114.74M | -5.28% | 6,656,507 | 32.88M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 114.00M | -0.60% | 808,171 | 65.34K |
| 356 | GNLX | Genelux Corporation | 113.81M | -1.93% | 106,658 | 8.00K |
| 357 | RANI | Rani Therapeutics Holdings, Inc. | 112.17M | -3.36% | 1,190,204 | 1.20M |
| 358 | ALDX | Aldeyra Therapeutics, Inc. | 110.13M | 28.87% | 12,004,883 | - |
| 359 | AARD | Aardvark Therapeutics, Inc. | 106.69M | 0.41% | 215,668 | - |
| 360 | GOSS | Gossamer Bio, Inc. | 106.08M | 4.12% | 10,720,788 | 48.47M |
| 361 | ONCY | Oncolytics Biotech Inc. | 105.34M | 1.92% | 635,392 | - |
| 362 | TTRX | Turn Therapeutics Inc. | 101.00M | -1.44% | 29,144 | - |
| 363 | COYA | Coya Therapeutics, Inc. | 100.16M | -4.04% | 206,666 | 7.95M |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 99.64M | 1.58% | 127,307 | 35.58M |
| 365 | QTTB | Q32 Bio Inc. | 97.58M | 14.80% | 345,468 | 53.74M |
| 366 | FBIO | Fortress Biotech, Inc. | 97.46M | -0.63% | 223,600 | 62.30M |
| 367 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 97.38M | -55.43% | 9,572,964 | - |
| 368 | SEER | Seer, Inc. | 97.33M | -0.86% | 114,698 | 16.58M |
| 369 | PYXS | Pyxis Oncology, Inc. | 95.89M | 0.65% | 165,859 | 2.82M |
| 370 | CGTX | Cognition Therapeutics, Inc. | 95.34M | -1.82% | 827,337 | - |
| 371 | ANIX | Anixa Biosciences, Inc. | 92.87M | - | 82,467 | - |
| 372 | HURA | TuHURA Biosciences, Inc. | 91.75M | -4.79% | 515,238 | - |
| 373 | DWTX | Dogwood Therapeutics, Inc. | 90.69M | -8.59% | 108,017 | - |
| 374 | CING | Cingulate Inc. | 87.33M | -6.59% | 1,118,762 | - |
| 375 | MCRB | Seres Therapeutics, Inc. | 87.04M | 0.55% | 24,235 | 789.00K |
| 376 | KZIA | Kazia Therapeutics Limited | 86.19M | 5.33% | 116,854 | 1.20M |
| 377 | CSBR | Champions Oncology, Inc. | 86.10M | 6.35% | 18,812 | 57.95M |
| 378 | VANI | Vivani Medical, Inc. | 83.90M | -1.71% | 232,835 | - |
| 379 | PLRX | Pliant Therapeutics, Inc. | 82.35M | 3.91% | 324,684 | - |
| 380 | ATYR | aTyr Pharma, Inc. | 81.15M | 1.55% | 1,055,414 | 190.00K |
| 381 | SPRB | Spruce Biosciences, Inc. | 81.01M | 0.50% | 37,923 | 697.00K |
| 382 | NRXS | NeurAxis, Inc. | 80.10M | 2.43% | 406,412 | 3.57M |
| 383 | PMVP | PMV Pharmaceuticals, Inc. | 79.99M | 0.67% | 352,605 | - |
| 384 | PYPD | PolyPid Ltd. | 79.55M | -0.46% | 31,740 | - |
| 385 | BMEA | Biomea Fusion, Inc. | 77.07M | -6.84% | 1,540,355 | - |
| 386 | ANVS | Annovis Bio, Inc. | 75.71M | 8.10% | 622,825 | - |
| 387 | PTHS | Pelthos Therapeutics Inc. | 74.31M | -4.62% | 8,571 | 16.80M |
| 388 | IBIO | iBio, Inc. | 72.54M | -4.11% | 1,200,387 | 300.00K |
| 389 | XBIT | XBiotech Inc. | 71.65M | 4.44% | 297,058 | - |
| 390 | COEP | Coeptis Therapeutics Holdings, Inc. | 70.32M | 1.71% | 23,680 | 501.00K |
| 391 | GANX | Gain Therapeutics, Inc. | 68.59M | -2.56% | 702,187 | - |
| 392 | MNOV | MediciNova, Inc. | 68.42M | -1.42% | 30,513 | 409.66K |
| 393 | ACET | Adicet Bio, Inc. | 67.85M | 2.02% | 97,319 | - |
| 394 | GRCE | Grace Therapeutics, Inc. | 67.78M | -1.35% | 259,741 | - |
| 395 | ACRV | Acrivon Therapeutics, Inc. | 65.87M | 3.66% | 802,520 | - |
| 396 | BYSI | BeyondSpring Inc. | 62.92M | -12.85% | 35,443 | 1.88M |
| 397 | ATHE | Alterity Therapeutics Limited | 62.53M | -1.43% | 1,455 | 4.43M |
| 398 | EXOZ | eXoZymes, Inc. | 61.90M | 3.51% | 5,201 | -700.00 |
| 399 | IFRX | InflaRx N.V. | 61.62M | 3.36% | 732,266 | 34.44K |
| 400 | IMA | ImageneBio, Inc. | 60.62M | -2.40% | 52,790 | 800.00K |
| 401 | HYFT | MindWalk Holdings Corp. | 60.59M | 5.17% | 121,644 | 20.70M |
| 402 | IMMP | Immutep Limited | 60.56M | -0.70% | 1,290,443 | 5.28M |
| 403 | EDSA | Edesa Biotech, Inc. | 60.36M | -5.98% | 569,438 | - |
| 404 | OKUR | OnKure Therapeutics, Inc. | 59.89M | 9.23% | 209,506 | - |
| 405 | GUTS | Fractyl Health, Inc. | 59.83M | -1.87% | 748,338 | 3.00K |
| 406 | TCRX | TScan Therapeutics, Inc. | 59.18M | -2.80% | 653,877 | 10.33M |
| 407 | ACTU | Actuate Therapeutics, Inc. | 58.11M | -0.79% | 116,693 | - |
| 408 | MREO | Mereo BioPharma Group plc | 57.57M | 2.56% | 1,819,448 | 500.00K |
| 409 | TIL | Instil Bio, Inc. | 57.51M | 1.68% | 16,203 | - |
| 410 | RADX | Radiopharm Theranostics Limited | 55.76M | 0.43% | 19,954 | 10.86M |
| 411 | ICCC | ImmuCell Corporation | 55.63M | 1.82% | 3,906 | 27.64M |
| 412 | MAIA | MAIA Biotechnology, Inc. | 55.55M | 0.67% | 434,552 | - |
| 413 | MGX | Metagenomi Therapeutics, Inc. | 55.30M | 2.08% | 211,559 | 25.21M |
| 414 | ENTX | Entera Bio Ltd. | 54.57M | -11.19% | 287,997 | 124.00K |
| 415 | LPCN | Lipocine Inc. | 53.36M | 0.14% | 81,455 | 1.98M |
| 416 | OSTX | OS Therapies Incorporated | 52.82M | -0.66% | 348,035 | - |
| 417 | NRXP | NRx Pharmaceuticals, Inc. | 51.70M | -3.16% | 652,486 | 242.00K |
| 418 | DCOY | Decoy Therapeutics Inc. | 50.98M | 0.50% | 12,827 | - |
| 419 | IBO | Impact BioMedical Inc. | 49.92M | 1.71% | 188,440 | 32.00K |
| 420 | KZR | Kezar Life Sciences, Inc. | 49.03M | -1.69% | 13,433 | - |
| 421 | RLYB | Rallybio Corporation | 48.08M | -2.88% | 140,372 | 858.00K |
| 422 | NTRB | Nutriband Inc. | 47.54M | 0.51% | 10,126 | 2.28M |
| 423 | INKT | MiNK Therapeutics, Inc. | 45.72M | 2.96% | 50,405 | - |
| 424 | ALGS | Aligos Therapeutics, Inc. | 45.42M | 5.61% | 46,605 | 2.19M |
| 425 | TELO | Telomir Pharmaceuticals, Inc. | 45.38M | 3.94% | 60,246 | - |
| 426 | LSTA | Lisata Therapeutics, Inc. | 45.34M | 0.20% | 82,639 | 170.00K |
| 427 | ATOS | Atossa Therapeutics, Inc. | 44.18M | 0.39% | 65,958 | - |
| 428 | GOVX | GeoVax Labs, Inc. | 42.98M | 0.70% | 60,491 | 3.35M |
| 429 | LITS | Lite Strategy, Inc. | 42.54M | -0.85% | 236,115 | - |
| 430 | ATRA | Atara Biotherapeutics, Inc. | 41.87M | 2.40% | 83,878 | 120.77M |
| 431 | ESLA | Estrella Immunopharma, Inc. | 41.54M | 1.85% | 54,197 | - |
| 432 | PSTV | Plus Therapeutics, Inc. | 41.36M | 2.16% | 3,586,907 | 5.21M |
| 433 | APLM | Apollomics, Inc. | 41.01M | -2.05% | 12,062 | 6.93M |
| 434 | CMMB | Chemomab Therapeutics Ltd. | 39.94M | -3.50% | 48,375 | - |
| 435 | PTN | Palatin Technologies, Inc. | 39.45M | -4.28% | 3,191 | 8.96M |
| 436 | HOWL | Werewolf Therapeutics, Inc. | 39.32M | -3.91% | 181,996 | 1.14M |
| 437 | CRVO | CervoMed Inc. | 39.16M | -0.24% | 92,802 | 4.01M |
| 438 | LONA | LeonaBio, Inc. | 39.16M | 1.53% | 84,202 | - |
| 439 | SNSE | Sensei Biotherapeutics, Inc. | 38.54M | 0.07% | 91,664 | - |
| 440 | RNXT | RenovoRx, Inc. | 37.02M | -1.94% | 475,720 | 928.00K |
| 441 | VERU | Veru Inc. | 36.76M | -0.43% | 52,585 | 16.89M |
| 442 | CELU | Celularity Inc. | 36.62M | 1.60% | 30,474 | 40.58M |
| 443 | NXTC | NextCure, Inc. | 35.89M | -13.18% | 26,672 | - |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 34.52M | 6.98% | 104,608 | - |
| 445 | RNTX | Rein Therapeutics Inc. | 34.17M | -2.99% | 78,881 | - |
| 446 | JSPR | Jasper Therapeutics, Inc. | 34.14M | - | 191,737 | - |
| 447 | ATNM | Actinium Pharmaceuticals, Inc. | 34.00M | -0.91% | 57,239 | 90.00K |
| 448 | ABVC | ABVC BioPharma, Inc. | 32.82M | 5.74% | 66,153 | 797.92K |
| 449 | BCTX | BriaCell Therapeutics Corp. | 32.73M | 4.87% | 220,925 | - |
| 450 | NBY | NovaBay Pharmaceuticals, Inc. | 32.48M | -4.69% | 250,817 | 10.30M |
| 451 | INMB | INmune Bio Inc. | 32.43M | -1.61% | 377,651 | 50.00K |
| 452 | PLUR | Pluri Inc. | 31.46M | -4.86% | 12,866 | 1.34M |
| 453 | CVM | CEL-SCI Corporation | 30.96M | 1.95% | 16,347 | - |
| 454 | PDSB | PDS Biotechnology Corporation | 30.62M | -3.77% | 435,800 | - |
| 455 | XCUR | Exicure, Inc. | 30.28M | 7.22% | 18,406 | 500.00K |
| 456 | TLSA | Tiziana Life Sciences Ltd | 29.94M | - | 46,768 | - |
| 457 | KYNB | Kyntra Bio, Inc. | 29.54M | 3.55% | 60,007 | 6.44M |
| 458 | HYPD | Hyperion DeFi, Inc. | 29.48M | -3.45% | 580,839 | 345.32K |
| 459 | TPST | Tempest Therapeutics, Inc. | 29.12M | - | 37,359 | - |
| 460 | DYAI | Dyadic International, Inc. | 28.89M | 2.35% | 25,278 | 3.34M |
| 461 | OTLK | Outlook Therapeutics, Inc. | 27.93M | -3.94% | 1,939,974 | 205.70K |
| 462 | XLO | Xilio Therapeutics, Inc. | 27.34M | -4.08% | 51,630 | 31.80M |
| 463 | SER | Serina Therapeutics, Inc. | 26.45M | 93.75% | 157,695,983 | 116.00K |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 26.34M | 1.83% | 145,164 | - |
| 465 | LGVN | Longeveron Inc. | 25.83M | 13.71% | 3,164,141 | 1.20M |
| 466 | CUE | Cue Biopharma, Inc. | 25.80M | -0.08% | 1,366,428 | 27.47M |
| 467 | BOLD | Boundless Bio, Inc. | 25.77M | -1.71% | 21,513 | - |
| 468 | ENLV | Enlivex Ltd. | 25.77M | -0.92% | 88,600 | - |
| 469 | BRNS | Barinthus Biotherapeutics plc | 25.73M | -1.39% | 38,278 | 14.97M |
| 470 | VTGN | Vistagen Therapeutics, Inc. | 25.45M | 5.30% | 501,069 | 789.00K |
| 471 | IGC | IGC Pharma, Inc. | 25.26M | -1.27% | 155,864 | 1.11M |
| 472 | LTRN | Lantern Pharma Inc. | 24.16M | -5.68% | 70,221 | - |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 23.72M | -3.72% | 25,590 | 14.99M |
| 474 | SNTI | Senti Biosciences, Inc. | 23.68M | -7.17% | 226,656 | - |
| 475 | PASG | Passage Bio, Inc. | 23.67M | 4.98% | 27,462 | - |
| 476 | NNVC | NanoViricides, Inc. | 22.67M | -6.25% | 296,750 | - |
| 477 | MRKR | Marker Therapeutics, Inc. | 22.01M | -1.49% | 117,967 | 3.55M |
| 478 | SKYE | Skye Bioscience, Inc. | 21.87M | -2.67% | 160,949 | - |
| 479 | VYNE | VYNE Therapeutics Inc. | 20.64M | 6.82% | 505,549 | 570.00K |
| 480 | ACXP | Acurx Pharmaceuticals, Inc. | 18.93M | 27.26% | 7,797,347 | - |
| 481 | DARE | Daré Bioscience, Inc. | 18.58M | -7.14% | 127,240 | -57.13K |
| 482 | CTXR | Citius Pharmaceuticals, Inc. | 18.18M | -1.60% | 386,480 | 3.94M |
| 483 | KTTA | Pasithea Therapeutics Corp. | 18.06M | -4.62% | 114,538 | - |
| 484 | LEXX | Lexaria Bioscience Corp. | 18.04M | -2.68% | 97,659 | 522.00K |
| 485 | TRAW | Traws Pharma, Inc. | 17.42M | 7.92% | 61,033 | 2.85M |
| 486 | ALLR | Allarity Therapeutics, Inc. | 17.39M | -5.98% | 161,857 | - |
| 487 | FBLG | FibroBiologics, Inc. | 17.30M | -1.77% | 407,617 | - |
| 488 | INAB | IN8bio, Inc. | 16.94M | -6.52% | 36,774 | - |
| 489 | LIXT | Lixte Biotechnology Holdings, Inc. | 16.60M | 3.19% | 16,298 | - |
| 490 | INTS | Intensity Therapeutics, Inc. | 16.04M | -2.31% | 25,083 | - |
| 491 | AEON | AEON Biopharma, Inc. | 15.59M | -0.88% | 13,159 | - |
| 492 | ARTL | Artelo Biosciences, Inc. | 15.21M | -2.05% | 907,847 | - |
| 493 | COCP | Cocrystal Pharma, Inc. | 15.02M | -3.54% | 18,456 | - |
| 494 | CVKD | Cadrenal Therapeutics, Inc. | 14.47M | -3.73% | 32,298 | - |
| 495 | HOTH | Hoth Therapeutics, Inc. | 14.33M | -6.73% | 517,222 | - |
| 496 | PHIO | Phio Pharmaceuticals Corp. | 13.71M | -1.67% | 304,451 | - |
| 497 | IOBT | IO Biotech, Inc. | 13.67M | 3.60% | 1,200,116 | - |
| 498 | CLRB | Cellectar Biosciences, Inc. | 13.48M | -2.15% | 41,182 | - |
| 499 | GTBP | GT Biopharma, Inc. | 13.42M | -0.84% | 557,844 | - |
| 500 | QNRX | Quoin Pharmaceuticals, Ltd. | 13.35M | 5.36% | 13,505 | - |
| 501 | PLRZ | Polyrizon Ltd. | 13.23M | -6.32% | 21,370 | - |
| 502 | JUNS | Jupiter Neurosciences, Inc. | 12.99M | 1.95% | 167,514 | - |
| 503 | KAPA | Kairos Pharma, Ltd. | 12.81M | 1.15% | 182,274 | - |
| 504 | BCDA | BioCardia, Inc. | 12.74M | -2.44% | 36,224 | 3.00K |
| 505 | SNGX | Soligenix, Inc. | 12.31M | - | 119,762 | 2.34K |
| 506 | GDTC | CytoMed Therapeutics Limited | 12.12M | - | 13,779 | 573.19K |
| 507 | GNTA | Genenta Science S.p.A. | 11.97M | -9.39% | 137,589 | - |
| 508 | CALC | CalciMedica, Inc. | 11.61M | -10.32% | 308,004 | - |
| 509 | BLRX | BioLineRx Ltd. | 11.55M | 3.41% | 6,416 | 12.74M |
| 510 | OSRH | OSR Holdings, Inc. | 11.38M | 2.35% | 398,953 | -90.52K |
| 511 | NCEL | NewcelX Ltd. | 11.17M | -6.49% | 8,282 | - |
| 512 | BIVI | BioVie Inc. | 11.01M | 3.55% | 44,207 | - |
| 513 | MBRX | Moleculin Biotech, Inc. | 10.99M | -0.96% | 50,429 | - |
| 514 | CRIS | Curis, Inc. | 9.79M | -7.14% | 397,856 | 9.44M |
| 515 | LNAI | Lunai Bioworks Inc. | 9.31M | -4.21% | 7,596,458 | - |
| 516 | BCAB | BioAtla, Inc. | 9.19M | -2.31% | 940,882 | 11.00M |
| 517 | IMNN | Imunon, Inc. | 9.06M | -0.67% | 23,228 | - |
| 518 | ITRM | Iterum Therapeutics plc | 9.01M | -2.63% | 435,763 | 390.00K |
| 519 | QNTM | Quantum BioPharma Ltd. | 8.89M | -1.67% | 42,961 | - |
| 520 | APRE | Aprea Therapeutics, Inc. | 8.74M | 4.43% | 41,542 | 488.24K |
| 521 | BOLT | Bolt Biotherapeutics, Inc. | 8.72M | -2.05% | 4,172 | 7.70M |
| 522 | RNAZ | TransCode Therapeutics, Inc. | 8.54M | -2.51% | 11,494 | - |
| 523 | TOVX | Theriva Biologics, Inc. | 8.52M | 2.54% | 1,513,192 | - |
| 524 | ICU | SeaStar Medical Holding Corporation | 8.18M | -3.40% | 64,054 | 881.00K |
| 525 | PHGE | BiomX Inc. | 7.94M | -1.19% | 73,417 | - |
| 526 | ERNA | Ernexa Therapeutics Inc. | 7.87M | -8.16% | 1,039,513 | 1,000.00 |
| 527 | PULM | Pulmatrix, Inc. | 7.85M | 3.86% | 48,128 | 3.00K |
| 528 | CLGN | CollPlant Biotechnologies Ltd. | 7.79M | - | 10,651 | 2.48M |
| 529 | SPRC | SciSparc Ltd. | 7.56M | -0.43% | 8,518 | 1.31M |
| 530 | PMCB | PharmaCyte Biotech, Inc. | 7.54M | 0.29% | 81,287 | - |
| 531 | KPRX | Kiora Pharmaceuticals, Inc. | 7.47M | -1.93% | 56,749 | 20.00K |
| 532 | TCRT | Alaunos Therapeutics, Inc. | 7.39M | 1.22% | 10,601 | 6.00K |
| 533 | EVGN | Evogene Ltd. | 7.38M | -0.13% | 51,009 | 3.85M |
| 534 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.28M | 6.03% | 617,973 | 14.83K |
| 535 | ALZN | Alzamend Neuro, Inc. | 7.19M | -1.56% | 91,835 | - |
| 536 | NCNA | NuCana plc | 7.12M | -1.72% | 52,663 | - |
| 537 | ADXN | Addex Therapeutics Ltd | 7.12M | -1.19% | 1,575 | 198.82K |
| 538 | GRDX | GridAI Technologies Corp. | 7.03M | -2.34% | 20,513 | - |
| 539 | XBIO | Xenetic Biosciences, Inc. | 6.94M | -2.88% | 8,473 | 2.98M |
| 540 | MLEC | Moolec Science SA | 6.71M | -2.63% | 6,142 | 7.83M |
| 541 | PCSA | Processa Pharmaceuticals, Inc. | 6.20M | -26.27% | 145,867 | - |
| 542 | APM | Aptorum Group Limited | 5.95M | 19.71% | 429,215 | - |
| 543 | CYCN | Cyclerion Therapeutics, Inc. | 5.93M | 3.42% | 13,458 | 2.86M |
| 544 | IMRN | Immuron Limited | 5.79M | -0.28% | 11,384 | 4.99M |
| 545 | MBIO | Mustang Bio, Inc. | 5.72M | -1.13% | 64,494 | - |
| 546 | LIMN | Liminatus Pharma, Inc. | 5.43M | -5.42% | 2,362,351 | - |
| 547 | PBM | Psyence Biomedical Ltd. | 5.39M | -7.48% | 19,055 | - |
| 548 | XTLB | XTL Biopharmaceuticals Ltd. | 5.21M | -0.67% | 8,749 | 968.00K |
| 549 | AKTX | Akari Therapeutics, Plc | 5.20M | -10.46% | 1,192,405 | - |
| 550 | QNCX | Quince Therapeutics, Inc. | 4.88M | -9.59% | 15,547,095 | - |
| 551 | CELZ | Creative Medical Technology Holdings, Inc. | 4.85M | - | 20,158 | 6.00K |
| 552 | SLXN | Silexion Therapeutics Corp | 4.79M | -5.96% | 69,350 | - |
| 553 | VIVS | VivoSim Labs, Inc. | 4.64M | -1.11% | 59,332 | 142.00K |
| 554 | BGMS | Bio Green Med Solution, Inc. | 4.51M | 1.15% | 39,226 | 81.00K |
| 555 | REVB | Revelation Biosciences, Inc. | 4.46M | -1.64% | 82,194 | - |
| 556 | GNPX | Genprex, Inc. | 4.45M | -4.48% | 296,686 | - |
| 557 | SILO | Silo Pharma, Inc. | 4.34M | 1.88% | 93,896 | 72.10K |
| 558 | BDRX | Biodexa Pharmaceuticals Plc | 4.25M | -10.92% | 89,165 | 104.90K |
| 559 | APVO | Aptevo Therapeutics Inc. | 4.21M | -3.64% | 34,913 | - |
| 560 | INDP | Indaptus Therapeutics, Inc. | 3.95M | -5.88% | 5,157 | - |
| 561 | MTNB | Matinas BioPharma Holdings, Inc. | 3.78M | -0.84% | 16,638 | - |
| 562 | GRI | GRI Bio, Inc. | 3.77M | -1.51% | 12,471 | - |
| 563 | PPBT | Purple Biotech Ltd | 3.52M | -0.56% | 6,032 | - |
| 564 | ASBP | Aspire Biopharma Holdings, Inc. | 3.30M | -5.96% | 241,940 | 1.94K |
| 565 | OGEN | Oragenics, Inc. | 3.26M | -4.54% | 42,798 | - |
| 566 | XRTX | XORTX Therapeutics Inc. | 3.25M | -2.24% | 28,862 | - |
| 567 | GLMD | Galmed Pharmaceuticals Ltd. | 3.20M | -4.61% | 10,215 | - |
| 568 | AZTR | Azitra, Inc. | 2.85M | 28.82% | 120,279,057 | 7.50K |
| 569 | ENVB | Enveric Biosciences, Inc. | 2.73M | -2.49% | 29,571 | - |
| 570 | ADIL | Adial Pharmaceuticals, Inc. | 2.67M | 10.00% | 36,550 | - |
| 571 | HCWB | HCW Biologics Inc. | 2.47M | -18.60% | 1,937,077 | 422.03K |
| 572 | BRTX | BioRestorative Therapies, Inc. | 2.27M | 11.93% | 3,252,575 | 383.40K |
| 573 | SCNI | Scinai Immunotherapeutics Ltd. | 2.22M | -0.70% | 9,559 | 1.15M |
| 574 | CLDI | Calidi Biotherapeutics, Inc. | 2.15M | -0.10% | 137,107 | - |
| 575 | BBLG | Bone Biologics Corporation | 2.08M | -4.13% | 10,229 | - |
| 576 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 2.04M | -8.96% | 294,818 | 1.36M |
| 577 | ENSC | Ensysce Biosciences, Inc. | 2.04M | -8.92% | 1,369,528 | 4.49M |
| 578 | KALA | KALA BIO, Inc. | 2.02M | -2.61% | 3,948,705 | - |
| 579 | PPCB | Propanc Biopharma, Inc. | 1.77M | 0.09% | 684,593 | - |
| 580 | ONCO | Onconetix, Inc. | 1.73M | -6.88% | 62,056 | 815.37K |
| 581 | JAGX | Jaguar Health, Inc. | 1.56M | -5.62% | 431,053 | 11.79M |
| 582 | DRMA | Dermata Therapeutics, Inc. | 1.42M | 1.68% | 2,769,047 | - |
| 583 | CNSP | CNS Pharmaceuticals, Inc. | 1.35M | -1.36% | 17,263 | - |
| 584 | CMND | Clearmind Medicine Inc. | 982.69K | -3.15% | 430,817 | - |
| 585 | OKYO | OKYO Pharma Limited | 932.66K | - | 115,469 | - |
| 586 | VRAX | Virax Biolabs Group Limited | 788.50K | -3.35% | 121,795 | 2.99K |
| 587 | CDT | CDT Equity Inc. | 785.37K | -5.12% | 72,858 | - |
| 588 | ADTX | Aditxt, Inc. | 699.31K | -11.35% | 143,419 | 5.95K |
| 589 | ELAB | PMGC Holdings Inc. | 318.18K | -12.06% | 47,144 | 285.95K |
| 590 | MTVA | MetaVia Inc. | 309.45K | - | 88,597 | - |
| 591 | CANF | Can-Fite BioPharma Ltd. | 18.95K | -3.20% | 38,650 | 560.00K |